# Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease

> **NCT00001872** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 14 (actual)

## Conditions studied

- Graft vs Host Disease
- Hematologic Neoplasm

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00001872
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02-02
- **Primary completion:** —
- **Final completion:** 2018-03-02
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001872, "Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00001872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*